Rep. Julia Letlow Discloses Over 200 Stock Trades After Deadline As Ban Debate Grows In Congress [Forbes]
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $157.00 to $152.00. They now have a "buy" rating on the stock.
AI Optical Coherence Tomography Market Opportunities to 2029 & 2034 by Type, Technology, Application and Region [Yahoo! Finance]
Why Abbott Laboratories (ABT) Story Is Shifting With Exact Sciences Deal Talk And Legal Wins [Yahoo! Finance]
PainTEQ Announces Appointment of Lalit Venkatesan, PhD as Senior Vice President of Clinical Research [Yahoo! Finance]